News Mental health startup NeuroFlow wins digital health challeng... NeuroFlow, a startup company focused on technology to support people with mental health issues has won a digital health challenge set by Otsuka.
News Novartis to develop digital therapies with Pear Deal covers digital therapies for MS and schizophrenia
News Janssen's depression drug shows promise in phase 2 Ketamine may be best known as an anaesthetic illegally used as a party drug, but Janssen has shown that it could also be reformulated and used as a treatment for depression.
News Otsuka recruits Medibio to pinpoint mental health biomarkers Medibio's technology will be used to gather mental health biomarkers related to Otsuka's Abilify.
R&D SpringWorks spins out of Pfizer on rare disease mission A new biotech spun out of Pfizer is to develop four drugs for rare and serious diseases.
Views & Analysis Progress in mental health digital innovation What new digital technologies are being introduced to help reduce mental illness?
News Pfizer takes 25-valent Prevnar follow-up into phase 3 Pfizer has upped the ante in the increasingly competitive market for pneumococcal vaccines with new data on a 25-valent candidate.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.